These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 19170800

  • 1. Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus.
    Hanyu H, Sato T, Kiuchi A, Sakurai H, Iwamoto T.
    J Am Geriatr Soc; 2009 Jan; 57(1):177-9. PubMed ID: 19170800
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.
    Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T.
    Neurobiol Aging; 2011 Sep; 32(9):1626-33. PubMed ID: 19923038
    [Abstract] [Full Text] [Related]

  • 3. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B, REAL.FR Study Group.
    Neurology; 2009 Oct 27; 73(17):1359-66. PubMed ID: 19858457
    [Abstract] [Full Text] [Related]

  • 4. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K, Sankaralingam S, Ghosh M, Mereu L, Senior P.
    Discov Med; 2013 Dec 27; 16(90):277-86. PubMed ID: 24333407
    [Abstract] [Full Text] [Related]

  • 5. Sustained 4-year cognitive and functional response in early Alzheimer's disease with pioglitazone.
    Read S, Wu P, Biscow M.
    J Am Geriatr Soc; 2014 Mar 27; 62(3):584-6. PubMed ID: 24628640
    [No Abstract] [Full Text] [Related]

  • 6. Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease.
    Duron E, Rigaud AS, Dubail D, Mehrabian S, Latour F, Seux ML, Hanon O.
    Am J Hypertens; 2009 Sep 27; 22(9):1020-4. PubMed ID: 19590498
    [Abstract] [Full Text] [Related]

  • 7. The role of tumor necrosis factor-alpha in cognitive improvement after peroxisome proliferator-activator receptor gamma agonist pioglitazone treatment in Alzheimer's disease.
    Hanyu H, Sato T, Sakurai H, Iwamoto T.
    J Am Geriatr Soc; 2010 May 27; 58(5):1000-1. PubMed ID: 20722838
    [No Abstract] [Full Text] [Related]

  • 8. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C, Cantisani TA, Celani MG, Incorvaia B, Righetti E, Candelise L, Cochrane Neurological Network.
    Neuroepidemiology; 2007 May 27; 28(2):116-7. PubMed ID: 17409773
    [No Abstract] [Full Text] [Related]

  • 9. Pioglitazone-induced heart failure despite normal left ventricular function.
    Shah M, Kolandaivelu A, Fearon WF.
    Am J Med; 2004 Dec 15; 117(12):973-4. PubMed ID: 15629744
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime.
    Leier CV, Haas GJ.
    J Am Coll Cardiol; 2007 Jul 03; 50(1):37-9. PubMed ID: 17601543
    [No Abstract] [Full Text] [Related]

  • 13. Tacrine approved for cognitive deficits in Alzheimer's disease.
    Nurse Pract; 1994 Jan 03; 19(1):6-8. PubMed ID: 8139805
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment strategies for the cognitive deficits of Alzheimer's disease.
    Meador KJ.
    J S C Med Assoc; 1994 Nov 03; 90(11):543-7. PubMed ID: 7853858
    [No Abstract] [Full Text] [Related]

  • 16. Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report.
    Collet-Gaudillat C, Billon-Bancel A, Beressi JP.
    Diabetes Metab; 2009 Apr 03; 35(2):151-4. PubMed ID: 19249234
    [Abstract] [Full Text] [Related]

  • 17. Pioglitazone for the treatment of Alzheimer's disease.
    Galimberti D, Scarpini E.
    Expert Opin Investig Drugs; 2017 Jan 03; 26(1):97-101. PubMed ID: 27885860
    [Abstract] [Full Text] [Related]

  • 18. [Diabetes, heart, and glitazones].
    Philippe J.
    Rev Med Suisse Romande; 2004 Mar 03; 124(3):133-5. PubMed ID: 15095655
    [No Abstract] [Full Text] [Related]

  • 19. Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation.
    Liu C, Liu T, Li G.
    Int J Cardiol; 2013 Sep 30; 168(2):1603-5. PubMed ID: 23414743
    [No Abstract] [Full Text] [Related]

  • 20. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan 30; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.